The Lancet HIV in conversation with

Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The...

Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips...

In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to...

Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new...

Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into...

Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the...

In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez...

Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the...

Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and...

Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding...

Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell...

Please note: this podcast is entirely in Spanish Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra...

Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to...

Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV. Read this month´s anniversary editorial here...

Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission. Read the...

Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses. Continue this conversation on social! Follow us...

Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre...

Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo. Read the full article...

Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana)...

Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America. Read the full...

Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London...

Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention...

Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV...

Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability...